1. Home
  2. ITRM vs MGLD Comparison

ITRM vs MGLD Comparison

Compare ITRM & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • MGLD
  • Stock Information
  • Founded
  • ITRM 2015
  • MGLD 1996
  • Country
  • ITRM Ireland
  • MGLD United States
  • Employees
  • ITRM N/A
  • MGLD N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • MGLD Finance/Investors Services
  • Sector
  • ITRM Health Care
  • MGLD Finance
  • Exchange
  • ITRM Nasdaq
  • MGLD Nasdaq
  • Market Cap
  • ITRM 40.0M
  • MGLD 35.8M
  • IPO Year
  • ITRM 2018
  • MGLD N/A
  • Fundamental
  • Price
  • ITRM $0.82
  • MGLD $0.93
  • Analyst Decision
  • ITRM Strong Buy
  • MGLD
  • Analyst Count
  • ITRM 2
  • MGLD 0
  • Target Price
  • ITRM $7.00
  • MGLD N/A
  • AVG Volume (30 Days)
  • ITRM 751.2K
  • MGLD 11.0K
  • Earning Date
  • ITRM 08-13-2025
  • MGLD 09-17-2025
  • Dividend Yield
  • ITRM N/A
  • MGLD N/A
  • EPS Growth
  • ITRM N/A
  • MGLD N/A
  • EPS
  • ITRM N/A
  • MGLD N/A
  • Revenue
  • ITRM N/A
  • MGLD $31,205,000.00
  • Revenue This Year
  • ITRM N/A
  • MGLD N/A
  • Revenue Next Year
  • ITRM $270.19
  • MGLD N/A
  • P/E Ratio
  • ITRM N/A
  • MGLD N/A
  • Revenue Growth
  • ITRM N/A
  • MGLD N/A
  • 52 Week Low
  • ITRM $0.81
  • MGLD $0.70
  • 52 Week High
  • ITRM $3.02
  • MGLD $2.10
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 35.21
  • MGLD 56.82
  • Support Level
  • ITRM $0.81
  • MGLD $0.81
  • Resistance Level
  • ITRM $0.90
  • MGLD $0.97
  • Average True Range (ATR)
  • ITRM 0.08
  • MGLD 0.06
  • MACD
  • ITRM -0.02
  • MGLD 0.01
  • Stochastic Oscillator
  • ITRM 4.46
  • MGLD 73.45

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

Share on Social Networks: